Taliglucerase alfa in the longterm treatment of children and adolescents with type 1 Gaucher disease: the Albanian experience
IntroductionEnzyme replacement therapy is already recognized as the gold standard of care for patients with Gaucher disease. Taliglucerase alfa is one of the three alternatives recommended for treatment of Gaucher disease in children and adults.AimThis study aims to evaluate the long-term efficacy a...
Main Authors: | Paskal Cullufi, Sonila Tomori, Virtut Velmishi, Agim Gjikopulli, Ilir Akshija, Aferdita Tako, Ermira Dervishi, Gladiola Hoxha, Marjeta Tanka, Erjon Troja, Mirela Tabaku |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2024.1352179/full |
Similar Items
-
Skeletal Manifestations, Bone Pain, and BMD Changes in Albanian Type 1 Gaucher Patients Treated with Taliglucerase Alfa
by: Virtut Velmishi, et al.
Published: (2023-01-01) -
Late diagnosis of autism spectrum disorder and Sotos syndrome in a child with atypical symptomatology during infancy
by: Sonila Tomori, et al.
Published: (2023-01-01) -
Efficacy and Safety of Taliglucerase Alfa for the Treatment of Gaucher Disease: A 9-Year Experience
by: Livia d’Avila Paskulin, et al.
Published: (2022-05-01) -
A Rare Cause of Neonatal Hypotonia: First Case of Autosomal Recessive Fast-Channel Congenital Myasthenic Syndrome Type 1B in Albania
by: Eda Jazexhiu-Postoli, et al.
Published: (2025-03-01) -
Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS)
by: Lina Titievsky, et al.
Published: (2022-04-01)